An Exceedingly Rare Case of Liraglutide-Induced Liver Injury
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.
Saved in:
Main Authors: | Swetha Parvataneni, Rajarajeshwari Ramachandran, Eric Then, Tyler Grantham, Vinaya Gaduputi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Gastrointestinal Medicine |
Online Access: | http://dx.doi.org/10.1155/2021/6306149 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful Endoscopic Management of Oxyntic Gland Adenoma: A Case Report
by: Rajarajeshwari Ramachandran MD, et al.
Published: (2025-01-01) -
Adderall Induced Acute Liver Injury: A Rare Case and Review of the Literature
by: Rohini R. Vanga, et al.
Published: (2013-01-01) -
Liraglutide alleviates high-fat diet-induced kidney injury in mice by regulating the CaMKKβ/AMPK pathway
by: Yingli Xuan, et al.
Published: (2024-12-01) -
Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling
by: Jun Wang, et al.
Published: (2022-01-01) -
Tunde Kelani: The Man Exceeds the Frame
by: Toyin Falola
Published: (2021-12-01)